The Agilent microarray platform features the direct end-labeling and profiling of mature miRNAs from total RNA without any size fractionation or amplification to minimize experimental loss, bias, or variations [ 31, 32].
The RNA quality recovered from our LCM and isolation procedures is 37% with RIN ≥ 7, 39% with RIN ≥ 5 and 24% with RIN < 5. To minimize experimental variations, we chose to use Agilent miRNA microarray, since the platform features the direct end-labeling and profiling of mature miRNAs from total RNA without any size fractionation or amplification.
If inference methods are to be applied to data of the scale generated by modern microarray platforms, a feature selection step is usually required to reduce the size of the inference problem; attempts to apply network inference to such large-scale datasets may be premature, and consideration should be given to focusing the biological question to use smaller-scale higher-quality experimental data.
The BLO microarray platform has 17,328 spot features representing approximately 7,920 predicted bovine mRNA's spotted in duplicate supplemented with positive (GAPDH, RPL19, RPLP2, 28S RNA, 60S RNA, PPIA, ACTB, PGK1, B2M and GUSB), negative and artificial control sequences spotted multiple times.
An immunospecific bovine microarray platform (BOTL-4) with spot features representing 1336 genes was used for transcriptional profiling of PBMC from six M. bovis-infected cattle stimulated in vitro with bovine purified protein derivative of tuberculin (PPD-bovine).
However, the current microarray platform [ 1], with 10000 features, covers just 87% of the predicted genome and many newly annotated genes are missing [ 2].
An important feature of the microarray platform utilized in our study is the coverage of non-coding Synechocystis genes.
Gene expression changes were catalogued within each group using a reference hybridization design and a targeted immunospecific cDNA microarray platform (BOTL-5) with 4,800 spot features representing 1,391 genes.
This microarray platform contains 700,000 unique 25-mer oligonucleotide features (spots) representing 27,342 Entrez Gene IDs.
We demonstrate that barcode microarrays with smaller features are equally capable of detecting variation in DNA barcode intensity when compared to larger feature sizes within a specific microarray platform.
